Smith, Kenneth J.; Roberts, Mark S. - In: PharmacoEconomics 13 (1998) 5, pp. 645-651
Treatment of adult chickenpox with aciclovir is controversial because of the relatively high cost of medication and small proven benefits of therapy. A decision-tree model was used to estimate the cost effectiveness of aciclovir, from third-party payer and societal perspectives: the incremental...